People have long used all sorts of boosters to improve their brain functioning. The supplements used range from caffeine, ginkgo biloba pills, fish oil capsules to prescription stimulants.

The never-ending search for the write booster goes on and scientists are now wondering if healthy people should boost their brains with drugs, such as those prescribed for hyperactive children and those used to treat memory impairments in the aging.

Those in favor of the prescription stimulants believe that that the use of brain boosting drugs in healthy adults is a reasonable method of improving brain power and just as legitimate as education, the use of the internet and other learning tools. They are calling for the consideration of the issue in the commentary recently published in the journal Nature.

In their commentary, they state that using pills to achieve improved brain functioning is “no more ethically unacceptable than practicing healthy eating or being well rested”.

Currently, around 7 % of the students have used prescription stimulants, and on some campuses, as many as 25 % have used the drugs for non-therapeutic purposes and the demand is going to grow especially among middle-aged people looking to improve memory function and workers who need to multitask to keep track of demands.
The scientist are calling for more research , risks assessment as well as steps for risk management as more effective pills are being developed.
If the pills prove effective in healthy individuals and risk free, almost everybody would want to use them.

Previous researches have shown that prescription stimulants such as Ritalin and Adderal, Provigil approved for sleep disorders and some drugs used to treat Alzheimer's disease helped healthy people focus their attention and manage information in their brains.

What the scientists are worried about are the long-term effects on healthy people as well as possibilities for addiction. They have made an appeal for doctors and educators as well as regulators to take part in the evaluation of the risks and to develop policies to govern the use of these drugs.